Prophylactic and symptomatic treatment of influenza: Current and developing options

Postgraduate Medicine

Volumn 109, Issue 1, 2001, Pages 97-105

  Mossad, Sherif B ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; CIMETIDINE; INFLUENZA VACCINE; OSELTAMIVIR; RIMANTADINE; ZANAMIVIR;

ARTICLE; BRONCHOSPASM; CONFUSION; COST EFFECTIVENESS ANALYSIS; DROWSINESS; DRUG COST; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; GASTROINTESTINAL SYMPTOM; HUMAN; INFLUENZA; PROPHYLAXIS; SEIZURE; SYMPTOM;

EID: 0035151653     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2001.01.827     Document Type: Article

References (33)

1. Delayed supply of influenza vaccine and adjunct ACIP influenza vaccine recommendations for the 2000-01 influenza season
2. Health impact of influenza in the United States
3. National Center for Health Statistics. Fast stats A to Z. Deaths/Mortality
4. Update: Influenza activity - United States and worldwide, 1999-2000 season, and composition of the 2000-01 influenza vaccine
5. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections
6. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections
7. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza
8. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections
9. "High risk" and otherwise healthy patients demonstrate alleviation of influenza symptoms 2.5 days earlier following inhaled zanamivir treatment: European study, winter 1997-8
10. Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: A randomized controlled trial
11. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: Randomized controlled trials for prevention and treatment
12. Oral GS4104 treatment of acute influenza benefits health and activity measures
13. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: A randomized controlled trial
14. Efficacy and safety of oseltamivir in treatment of acute influenza: A randomised controlled trial
15. Efficacy of oral oseltamivir in experimental human influenza B virus infection
16. Short-term treatment with zanamivir to prevent influenza: Results of a placebo-controlled study
17. Zanamivir in the prevention of influenza among healthy adults: A randomized controlled trial
18. Safety and efficacy of intravenous zanamivir in preventing experimental human influenza A virus infection
19. Efficacy of zanamivir for chemoprophylaxis of nursing home influenza outbreaks
20. Use of zanamivir (ZA) to control an outbreak of influenza A (Flu A)
21. Utility of zanamivir (Z) for the treatment and prophylaxis of concomitant influenza A (IA) and B (IB) infection in a complex continuing care (CCC) and medical rehabilitation (MR) population
22. Inhaled zanamivir for the prevention of influenza in families
23. Safety and efficacy of once daily intranasal zanamivir in preventing experimental human influenza infection
24. Use of the selective oral neuramimdase inhibitor oseltamivir to prevent influenza
25. Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: Pooled efficacy analysis
26. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease
27. Efficacy of influenza vaccination in HIV-infected persons: A randomized, double-blind, placebo-controlled trial
28. Effectiveness of influenza vaccine in health care professionals a randomized trial
29. Use of live attentuated, cold-adapted influenza A reassortant virus vaccines in infants, children, young adults, and elderly adults
30. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children
31. Greater effectiveness from zanamivir treatment of influenza with antecedent influenza vaccination in older adults
32. Effect of oral treatment with the neuraminidase inhibitor RWJ-270201 on influenza virus infections in immunosuppressed mice
33. Disarming flu viruses